SCHEMBL4768151

SCHEMBL4768151

O=C(NCc1ccc(C(F)(F)F)nc1)c1ccc(NS(=O)(=O)CCc2ccccc2Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
DGAT2 Q96PD7 1/20 0.47
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
ITK Q08881 2/20 0.45
SCN3A Q9NY46 2/20 0.44
NAMPT P43490 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 1/20 0.42
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767854 0.93 MAPT (0.46) MAPTDGAT2PPARGPPARAITK
SCHEMBL5572196 0.88 PPARA (0.42) MAPTDGAT2PPARGPPARAITK
SCHEMBL4776425 0.88 TDP1 (0.42) MAPTDGAT2PPARGPPARAITK
SCHEMBL4777709 0.85 PPARG (0.48) MAPTDGAT2PPARGPPARAITK
SCHEMBL4774981 0.84 MAPT (0.46) MAPTDGAT2PPARGPPARAITK
SCHEMBL5568785 0.83 SCN3A (0.43) MAPTDGAT2PPARGPPARAITK
SCHEMBL4768011 0.82 ALDH1A1 (0.62) NAMPTTDP1CA2GAAMEN1
SCHEMBL4773250 0.82 SCN3A (0.51) PPARGPPARAITKSCN3ANAMPT
SCHEMBL4774976 0.82 ITK (0.46) MAPTDGAT2PPARGPPARAITK
SCHEMBL4775016 0.82 DGAT2 (0.46) MAPTDGAT2ITKSCN3ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 MAPT 294/4885DGAT2 3173/4885PPARG 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.